Literature DB >> 1730054

Enhancement of DNA transfection efficiency by heat treatment of cultured mammalian cells.

T Takai1, H Ohmori.   

Abstract

The expression of genes introduced into various mammalian cell lines was enhanced by raising the temperature of the cells to 42 degrees C for a few hours after DNA transfection. This heat treatment resulted in an up to 10-fold increase in the frequency of the cells that transiently expressed a foreign gene such as that of beta-galactosidase, whereas it had only a limited enhancing effect on the development of stable transformants. By immunotitration analysis, it was confirmed that the enhanced expression of beta-galactosidase activity correlated well with the increase of the enzyme protein. This procedure may have an applicability for augmenting the frequency of transient gene expression in many cell types.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730054     DOI: 10.1016/0167-4781(92)90481-e

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of esophageal squamous cancers.

Authors:  Yaoping Shi; Jianfeng Wang; Zhibin Bai; Yonggang Li; Longhua Qiu; Bo Zhai; Feng Zhang; Xiaoming Yang
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

2.  Intravascular magnetic resonance/radiofrequency may enhance gene therapy for prevention of in-stent neointimal hyperplasia.

Authors:  Fabao Gao; Bensheng Qiu; Sourav Kar; Xiangcan Zhan; Lawrence V Hofmann; Xiaoming Yang
Journal:  Acad Radiol       Date:  2006-04       Impact factor: 3.173

Review 3.  Synergetic Thermal Therapy for Cancer: State-of-the-Art and the Future.

Authors:  Qizheng Dai; Bo Cao; Shiqing Zhao; Aili Zhang
Journal:  Bioengineering (Basel)       Date:  2022-09-15

4.  Orthotopic hepatic cancer: radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy.

Authors:  Fu Xiong; Feng Zhang; Yin Jin; Qiaoyou Weng; Jingjing Song; Guofeng Zhou; David Shin; Chuansheng Zheng; Xiaoming Yang
Journal:  Oncotarget       Date:  2017-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.